146 related articles for article (PubMed ID: 3456281)
1. Disposition and metabolism of [14-14C] 4-demethoxydaunorubicin HCl (idarubicin) and [14-14C]daunorubicin HCl in the rat. A comparative study.
Zini G; Vicario GP; Lazzati M; Arcamone F
Cancer Chemother Pharmacol; 1986; 16(2):107-15. PubMed ID: 3456281
[TBL] [Abstract][Full Text] [Related]
2. Disposition of 14C-labelled 4'-epidoxorubicin and doxorubicin in the rat. A comparative study.
Arcamone F; Lazzati M; Vicario GP; Zini G
Cancer Chemother Pharmacol; 1984; 12(3):157-66. PubMed ID: 6584234
[TBL] [Abstract][Full Text] [Related]
3. Disposition and metabolism of [14C]-haloperidol in rats.
Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
[TBL] [Abstract][Full Text] [Related]
4. Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies.
Ganzina F; Pacciarini MA; Di Pietro N
Invest New Drugs; 1986; 4(1):85-105. PubMed ID: 3516918
[TBL] [Abstract][Full Text] [Related]
5. Transplacental and mammary passage of radioactivity in rats treated vaginally and orally with [14C]propranolol.
Buttar HS; Moffatt JH; Bura C
J Toxicol Environ Health; 1988; 24(1):1-18. PubMed ID: 3373560
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumors.
Formelli F; Casazza AM; Di Marco A; Mariani A; Pollini C
Cancer Chemother Pharmacol; 1979; 3(4):261-9. PubMed ID: 294954
[TBL] [Abstract][Full Text] [Related]
7. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary metabolism and urinary excretion of 4-demethoxydaunorubicin as compared to daunorubicin in rats.
Catapano CV; Guaitani A; Broggini M; Corada M; Bartosek I; Italia C; Donelli MG
Anticancer Res; 1988; 8(4):725-31. PubMed ID: 3178163
[TBL] [Abstract][Full Text] [Related]
9. Disposition of decabromobiphenyl ether in rats dosed intravenously or by feeding.
el Dareer SM; Kalin JR; Tillery KF; Hill DL
J Toxicol Environ Health; 1987; 22(4):405-15. PubMed ID: 3694703
[TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
11. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
12. Antileukemic activity of 4-demethoxydaunorubicin in mice.
Casazza AM; Pratesi G; Giuliani F; Di Marco A
Tumori; 1980 Oct; 66(5):549-64. PubMed ID: 6936969
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
Frantz SW; Beskitt JL; Grosse CM; Tallant MJ; Dietz FK; Ballantyne B
Drug Metab Dispos; 1996 Aug; 24(8):911-21. PubMed ID: 8869828
[TBL] [Abstract][Full Text] [Related]
14. Disposition of [14C]methyl bromide in Fischer-344 rats after oral or intraperitoneal administration.
Medinsky MA; Bond JA; Dutcher JS; Birnbaum LS
Toxicology; 1984 Sep; 32(3):187-96. PubMed ID: 6433513
[TBL] [Abstract][Full Text] [Related]
15. Activity and distribution of iv and oral 4-demethoxydaunorubicin in murine experimental tumors.
Broggini M; Italia C; Colombo T; Marmonti L; Donelli MG
Cancer Treat Rep; 1984 May; 68(5):739-47. PubMed ID: 6586294
[TBL] [Abstract][Full Text] [Related]
16. 14C-NaVP and 14C-PEV repeated dose study in rat. Pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester.
Bertolino M; Acerbi D; Canali S; Giachetti C; Poli G; Ventura P; Zanolo G
Eur J Drug Metab Pharmacokinet; 1998; 23(2):223-9. PubMed ID: 9725486
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of 4-demethoxydaunorubicin (DMDR).
Lu K; Savaraj N; Kavanagh J; Feun LG; Burgess M; Bodey GP; Loo TL
Cancer Chemother Pharmacol; 1986; 17(2):143-8. PubMed ID: 3459594
[TBL] [Abstract][Full Text] [Related]
18. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
[TBL] [Abstract][Full Text] [Related]
20. Disposition of 9-aminoacridine in rats dosed orally or intravenously and in monkeys dosed topically.
el Dareer SM; Kalin JR; Tillery KF; Hill DL
J Toxicol Environ Health; 1985; 15(6):789-99. PubMed ID: 4057283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
